Guidelines for the clinical evaluation of lipid-altering agents in adults and children.
Saved in:
| Language: | English |
|---|---|
| Format: | Book E-Resource |
| _version_ | 1795891365150720000 |
|---|---|
| author2 | United States. Food and Drug Administration. Division of Metabolism and Endocrine Drug Products United States. Food and Drug Administration. Bureau of Drugs |
| author_browse | United States. Food and Drug Administration. Division of Metabolism and Endocrine Drug Products United States. Food and Drug Administration. Bureau of Drugs |
| author_facet | United States. Food and Drug Administration. Division of Metabolism and Endocrine Drug Products United States. Food and Drug Administration. Bureau of Drugs United States. Food and Drug Administration. Division of Metabolism and Endocrine Drug Products United States. Food and Drug Administration. Bureau of Drugs |
| building | Internet |
| collection | Hathi Collection |
| contents | Developed by the FDA Bureau of Drugs with the assistance of various advisory committees. "July 1980." HHS publication ; no (FDA) 80-3103. |
| ctrlnum | (OCoLC)7742025 |
| format | Book E-Resource |
| fullrecord | 01738cam a2200457 a 4500001001300000007000300013003000600016005001700022008004100039040002300080016001800103019001200121029001700133035003500150037002500185050001500210060002100225074001000246086002200256049000900278245009200287246004900379260018700428300001500615490004400630500009300674500001700767500004000784650003500824650002100859650004100880650001900921650002000940650002700960650002600987710010401013710006801117830004501185830003801230994001201268 ocm07742025 cr OCoLC 20100309033852.0 810620s1980 mdu o000 0 eng aNLM cNLM dGPO dVNN 7 a8104669 2DNLM a7321164 0 aNLM b8104669 a(OCoLC)7742025 z(OCoLC)7321164 a017-012-00288-9 bGPO 4 aRM300 b.U6 00 aQU 85 bG946 1980 a499-K 0 aHE 20.4208/2:L 66 aCGUA 00 aGuidelines for the clinical evaluation of lipid-altering agents in adults and children. 3 aLipid-altering agents in adults and children aRockville, Md. : bDivision of Metabolism and Endocrine Drug Products, Bureau of Drugs, Food and Drug Administration ; Washington : For sale by the Supt. of Docs., U.S. G.P.O., c1980. aiii, 10 p. 1 aFDA Bureau of Drugs clinical guidelines aDeveloped by the FDA Bureau of Drugs with the assistance of various advisory committees. a"July 1980." aHHS publication ; no (FDA) 80-3103. 2 aAntilipemic Agents xstandards. 2 aDrug Evaluation. 2 aHyperlipoproteinemias xdrug therapy. 2 aLipids xblood. 0 aDrugs xTesting. 0 aBlood lipids xTesting. 0 aHyperlipoproteinemia. 1 aUnited States. bFood and Drug Administration. b Division of Metabolism and Endocrine Drug Products. 1 aUnited States. bFood and Drug Administration. bBureau of Drugs. 0 aFDA Bureau of Drugs clinical guidelines. 0 aHHS publication ; v(FDA) 80-3103. aC0 bCGU |
| id | ocm07742025 |
| illustrated | Not Illustrated |
| import_time | 2024-04-09T20:44:28.045Z |
| institution | The University of Chicago |
| language | English |
| notes | Developed by the FDA Bureau of Drugs with the assistance of various advisory committees. "July 1980." HHS publication ; no (FDA) 80-3103. |
| oclc_num | 7742025 |
| physical | iii, 10 p. |
| publication_place | Rockville, Md. : |
| publishDate | 1980 |
| publisher | Division of Metabolism and Endocrine Drug Products, Bureau of Drugs, Food and Drug Administration ; Washington : For sale by the Supt. of Docs., U.S. G.P.O., |
| recordtype | hathi |
| series | FDA Bureau of Drugs clinical guidelines HHS publication |
| series2 | FDA Bureau of Drugs clinical guidelines HHS publication (FDA) 80-3103 |
| series_browse | FDA Bureau of Drugs clinical guidelines HHS publication |
| series_facet | FDA Bureau of Drugs clinical guidelines HHS publication |
| spelling | Guidelines for the clinical evaluation of lipid-altering agents in adults and children. Lipid-altering agents in adults and children Rockville, Md. : Division of Metabolism and Endocrine Drug Products, Bureau of Drugs, Food and Drug Administration ; Washington : For sale by the Supt. of Docs., U.S. G.P.O., 1980. iii, 10 p. FDA Bureau of Drugs clinical guidelines Developed by the FDA Bureau of Drugs with the assistance of various advisory committees. "July 1980." HHS publication ; no (FDA) 80-3103. Antilipemic Agents standards. Drug Evaluation. Hyperlipoproteinemias drug therapy. Lipids blood. Drugs Testing. Blood lipids Testing. Hyperlipoproteinemia. United States. Food and Drug Administration. Division of Metabolism and Endocrine Drug Products. United States. Food and Drug Administration. Bureau of Drugs. FDA Bureau of Drugs clinical guidelines. HHS publication ; (FDA) 80-3103. |
| spellingShingle | Guidelines for the clinical evaluation of lipid-altering agents in adults and children. FDA Bureau of Drugs clinical guidelines HHS publication Developed by the FDA Bureau of Drugs with the assistance of various advisory committees. "July 1980." HHS publication ; no (FDA) 80-3103. Antilipemic Agents standards Drug Evaluation Hyperlipoproteinemias drug therapy Lipids blood Drugs Testing Blood lipids Testing Hyperlipoproteinemia |
| title | Guidelines for the clinical evaluation of lipid-altering agents in adults and children. |
| title_alt | Lipid-altering agents in adults and children |
| title_alt_exact | Lipid-altering agents in adults and children |
| title_author | Guidelines for the clinical evaluation of lipid-altering agents in adults and children. |
| title_author_exact | Guidelines for the clinical evaluation of lipid-altering agents in adults and children. |
| title_browse | Guidelines for the clinical evaluation of lipid-altering agents in adults and children. Lipid-altering agents in adults and children |
| title_browse_sort | Guidelines for the clinical evaluation of lipid-altering agents in adults and children Lipid-altering agents in adults and children |
| title_full | Guidelines for the clinical evaluation of lipid-altering agents in adults and children. |
| title_fullStr | Guidelines for the clinical evaluation of lipid-altering agents in adults and children. |
| title_full_exact | Guidelines for the clinical evaluation of lipid-altering agents in adults and children. |
| title_full_unstemmed | Guidelines for the clinical evaluation of lipid-altering agents in adults and children. |
| title_short | Guidelines for the clinical evaluation of lipid-altering agents in adults and children. |
| title_short_exact | Guidelines for the clinical evaluation of lipid-altering agents in adults and children. |
| title_sort | guidelines for the clinical evaluation of lipid altering agents in adults and children |
| topic | Antilipemic Agents standards Drug Evaluation Hyperlipoproteinemias drug therapy Lipids blood Drugs Testing Blood lipids Testing Hyperlipoproteinemia |
| topic_browse | Antilipemic Agents Standards Drug Evaluation Hyperlipoproteinemias Drug Therapy Lipids Blood Drugs Testing Blood Lipids Testing Hyperlipoproteinemia |